Nuclear pore dysfunction and disease: a complex opportunity

Nucleus. 2024 Dec;15(1):2314297. doi: 10.1080/19491034.2024.2314297. Epub 2024 Feb 21.

Abstract

The separation of genetic material from bulk cytoplasm has enabled the evolution of increasingly complex organisms, allowing for the development of sophisticated forms of life. However, this complexity has created new categories of dysfunction, including those related to the movement of material between cellular compartments. In eukaryotic cells, nucleocytoplasmic trafficking is a fundamental biological process, and cumulative disruptions to nuclear integrity and nucleocytoplasmic transport are detrimental to cell survival. This is particularly true in post-mitotic neurons, where nuclear pore injury and errors to nucleocytoplasmic trafficking are strongly associated with neurodegenerative disease. In this review, we summarize the current understanding of nuclear pore biology in physiological and pathological contexts and discuss potential therapeutic approaches for addressing nuclear pore injury and dysfunctional nucleocytoplasmic transport.

Keywords: Neurodegenerative disease; nuclear envelope; nuclear pore complex; nucleocytoplasmic transport; nucleoporin; therapeutics.

Publication types

  • Review

MeSH terms

  • Active Transport, Cell Nucleus / physiology
  • Cell Nucleus / metabolism
  • Humans
  • Neurodegenerative Diseases* / metabolism
  • Nuclear Pore Complex Proteins / metabolism
  • Nuclear Pore* / metabolism

Substances

  • Nuclear Pore Complex Proteins

Grants and funding

This work was supported by: Answer ALS (JDR), NIH NIA R01 RF1AG062171 (JDR), Chan Zuckerberg Foundation (JDR), NIH NINDS 2P01NS084974, R01 NS122236 (JDR) R35 NS132179 (JDR), ALS Association (JDR), Muscular Dystrophy Association (JDR), Virginia Gentlemen Foundation (JDR), US Dept of Defense HT94252310136 (JDR), and F Prime (JDR).